Materials and methods for diagnosis
US-2024103020-A1 · Mar 28, 2024 · US
US9335290B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9335290-B2 |
| Application number | US-201213724383-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 21, 2012 |
| Priority date | Dec 23, 2011 |
| Publication date | May 10, 2016 |
| Grant date | May 10, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention relates generally to test devices and methods for performing optical and electrochemical assays and, more particularly, to test devices having the ability to perform optical and electrochemical assays on a sample and to methods of performing optical and electrochemical assays using such test devices. The present invention is particularly useful for performing immunoassays and/or electrochemical assays at the point-of-care.
Opening claim text (preview).
We claim: 1. A testing cartridge for detection of an analyte in a test sample, said testing cartridge comprising: a distribution port configured to receive said test sample; at least one electrochemical sensor; at least one chromatographic assay; a first conduit fluidically connected to the distribution port and configured to receive the test sample from the distribution port, the first conduit comprising said at least one chromatographic assay; a second conduit fluidically connected to the distribution port and configured to receive the test sample from the distribution port, the second conduit comprising said at least one electrochemical sensor; and a plurality of conductivity sensors configured to determine a position of said test sample in said first and second conduit. 2. The testing cartridge of claim 1 , wherein the first conduit comprises a labeled analyte for a competitive assay. 3. The testing cartridge of claim 1 , wherein the first conduit comprises a labeled antibody for a sandwich assay. 4. The testing cartridge of claim 2 , wherein said competitive assay comprises a label that is fluorescent or phosphorescent. 5. The testing cartridge of claim 3 , wherein said sandwich assay comprises a label that is fluorescent or phosphorescent. 6. The testing cartridge of claim 1 , wherein said at least one chromatographic assay is configured to detect said analyte selected from the group consisting of: hCG and drugs of abuse. 7. The testing cartridge of claim 1 , wherein said electrochemical sensor is configured to detect said analyte selected from the group consisting of: hCG, K, Na, Cl, Ca, Mg, pH, pO2, pCO2, glucose, urea, creatinine, lactate, CKMB, TnI, TnT, BNP, NTproBNP, proBNP, TSH, D-dimer, PSA, PTH, NGAL, galectin-3, AST, ALT, albumin, phosphate, and ALP. 8. A testing cartridge for detection of an analyte in a test sample, said testing cartridge comprising: an entry port for receiving said test sample into a holding chamber; a distribution port configured to receive said test sample from said holding chamber; at least one electrochemical sensor; at least one lateral flow test strip; a first conduit fluidically connected to the distribution port and configured to receive the test sample from the distribution port, the first conduit comprising said at least one lateral flow test strip; a second conduit fluidically connected to the distribution port and configured to receive the test sample from the distribution port, the second conduit comprising said at least one electrochemical sensor; and a plurality of conductivity sensors configured to determine a position of said test sample in said first and second conduit. 9. The testing cartridge of claim 8 , further comprising a barcode that comprises information identifying at least one of: said testing cartridge, an electrochemical test performed by said testing cartridge, and a lateral flow test performed by said testing cartridge. 10. The testing cartridge of claim 8 , wherein said at least one lateral flow test strip comprises a qualitative or semi-quantitative lateral flow test. 11. The testing cartridge of claim 10 , wherein said qualitative or semi-quantitative lateral flow test is configured to detect said analyte selected from the group consisting of: hCG and drugs of abuse. 12. The testing cartridge of claim 8 , wherein said electrochemical sensor is configured to detect said analyte selected from the group consisting of: hCG, K, Na, Cl, Ca, Mg, pH, pO2, pCO2, glucose, urea, creatinine, lactate, CKMB, TnI, TnT, BNP, NTproBNP, proBNP, TSH, D-dimer, PSA, PTH, NGAL, galectin-3, AST, ALT, albumin, phosphate, and ALP. 13. The testing cartridge of claim 8 , further comprising an imager chip configured to capture an image of a detection area of said at least one lateral flow test strip. 14. The testing cartridge of claim 13 , wherein said imager chip is a silicon biosensor chip configured to measure a light output of a photochemical reaction at said detection area. 15. The testing cartridge of claim 8 , further comprising a wash fluid reservoir with a displacement device configured to move a fluid from said wash fluid reservoir into said first conduit comprising said at least one lateral flow test strip and washing said test sample from said at least one lateral flow test strip. 16. The testing cartridge of claim 15 , wherein a volume of said fluid is in a range of about 10 uL to about 500 uL. 17. A testing cartridge for detection of an analyte in a test sample, said testing cartridge comprising: a distribution port configured to receive said test sample; a qualitative or semi-quantitative lateral flow test system; a quantitative non-lateral flow test system; a first conduit fluidically connected to the distribution port and configured to receive the test sample from the distribution port, the first conduit comprising said qualitative or semi-quantitative lateral flow test system; a second conduit fluidically connected to the distribution port and configured to receive the test sample from the distribution port, the second conduit comprising said quantitative non-lateral flow test system; and a plurality of conductivity sensors configured to determine a position of said test sample in said first and second conduit. 18. The testing cartridge of claim 17 , wherein said quantitative non-lateral flow test system is operable to detect the analyte selected from the group consisting of: hCG, K, Na, Cl, Ca, Mg, pH, pO2, pCO2, glucose, urea, creatinine, lactate, CKMB, TnI, TnT, BNP, NTproBNP, proBNP, TSH, D-dimer, PSA, PTH, NGAL, galectin-3, AST, ALT, albumin, phosphate and ALP. 19. The testing cartridge of claim 17 , wherein said qualitative or semi-quantitative lateral flow test system; and said quantitative non-lateral flow test system are configured to test for the analyte in a biological sample selected from the group consisting of: urine, blood, plasma, serum, and amended forms thereof.
characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title
Determining multiple analytes · CPC title
Association of two or more measuring systems or cells, each measuring a different parameter, where the measurement results may be either used independently, the systems or cells being physically associated, or combined to produce a value for a further parameter · CPC title
with fluid transport, e.g. in multi-compartment structures · CPC title
Electrodes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.